Cellvie

Who is Cellvie?

At cellvie, we believe in the power of cell-derived medicines. We are dedicated to bring about nothing short of a new treatment modality, to safe and improve the lives of patients in need. We take joy from and pride in facing the challenge of advancing medicine. A medicinal invention is only as meaningful as the products it spurs that reach patients in need. To turn Therapeutic Mitochondria Transplantation from an approach to a platform of products takes a team of individuals spellbound to realize the technology's potential.

Houston, United States

1-10 Employees

Founding year: 2018

Products & services of Cellvie

Product CELLVIE closes $5.5M of additional funding to accelerate the development of Therapeutic Mitochondria Transplantation image

Service

Verified

CELLVIE closes $5.5M of additional funding to accelerate the development of Therapeutic Mitochondria Transplantation

Harvard spin-off CELLVIE closes $5.5M of additional funding to accelerate the development of Therapeutic Mitochondria Transplantation as a new treatment modality. $5.5M financing led by Taiho Ventures LLC, with the participation of existing investors, including the Series Seed lead, Kizoo Technology Capital GmbH Fresh capital to be employed to get cellvie Series A ready by accelerating the development of the company’s technology platform, strengthening the team, and advancing the mitochondria’s GMP manufacturing

Go to website >

Product

Verified

CELLVIE wins in the category for Health Solutions at the Falling Walls Summit

Cellvie was privileged to be invited as one of Falling Walls Winners that were selected from more than 1300 submissions. Those fortunate presented astonishing innovations ranging from antibody-drug conjugates as next-generation cancer therapy (Tubulis) to quantum computing. Among this stellar competition, cellvie was selected as the Cluster Winner in Health Solutions 2022.

Go to website >

View all products

Keywords

Biotechnology

Life Science

Therapeutics

Industries

Other